Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| DexCom, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
This study proposes to examine the impact of time of day (morning versus afternoon) on the variability of blood glucose responses to high resistance exercise in a single group of patients with type 1 diabetes. Participants will be asked to wear a continuous glucose monitor during the 3 weeks of testing. During the six exercise sessions (three in the morning while fasted and three in the afternoon), participants will complete the same resistance exercise protocol.
Pre-test measures: Interested participants will be invited to the Physical Activity and Diabetes Laboratory on the main campus of the University of Alberta. They will be asked questions related to their physical activity levels and medication, and blood pressure will be measured to assess their eligibility. Where participants are eligible, anthropometric characteristics will be measured using standard protocols, as will blood pressure. A blood sample will be drawn for assessment of HbA1c. Participants will be introduced to the weight lifting equipment and the proper lifting techniques associated with each exercise prior to performing a standardized test to determine the maximum weight they can safely lift eight times while maintaining proper form (8 repetition maximum - 8RM).
Testing sessions: Participants will be asked to arrive at the lab either between 7 and 8 am in a fasting state, or between 4 pm and 5 pm. The three morning and three afternoon testing sessions will have identical exercise protocols. Participants will be asked to perform three sets of eight repetitions of seven different exercises (bench press leg press, shoulder press, leg curl, lat pulldown, abdominal crunches, seated row) at their pre-determined 8RM. Participants will be asked to match their food and insulin intake as closely as possible on testing days to avoid having these as confounders.
A continuous glucose monitor (CGM) sensor will be subcutaneously inserted by one of the investigators (trained by a group from the CGM manufacturer) into the anterior abdominal area of the participant in the morning of the day prior to the first testing session. CGM will store glucose data every 5 minutes for up to 7 days. During this time, participants will be asked to wear an accelerometer to allow for the objective assessment of background physical activity and sleep quality. Along with this device, they will fill out an activity and sleep log to improve the analysis of the data.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All participants | Experimental | There is only one study arm consisting of all participants. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fasted morning resistance exercise | Behavioral | On three separate occasions, participants will perform a standardized resistance exercise protocol in the morning while fasting. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Capillary glucose (change during exercise) | Using test strips and a hand-held glucometer to test blood from a finger poke | 0 minutes (exercise start), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Mean CGM glucose | mean CGM glucose | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| CGM coefficient of variation (CV) | coefficient of variation of continuous glucose monitoring data |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alberta Diabetes Institute | Edmonton | Alberta | T6G 2R3 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41831023 | Derived | McClure RD, Carr ALJ, Boule NG, Yardley JE. The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison. Diabetologia. 2026 Jul;69(7):1782-1791. doi: 10.1007/s00125-026-06713-6. Epub 2026 Mar 14. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Afternoon resistance exercise | Behavioral | On three separate occasions participants will perform a standardized resistance exercise protocol in the afternoon after eating their regular lunch |
|
| 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| CGM standard deviation (SD) | Standard deviation of CGM glucose | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| frequency of hypoglycemia | number of hypoglycemic events measured by CGM | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| frequency of hyperglycemia | number of hyperglycemic events measured by CGM | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| percent time in range | percent of time spent between 4.0 and 9.9 mmol/L | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| percent time in hyperglycemia | percent of time spent over 10.0 mmol/L | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| percent time in hypoglycemia | percent of time spent below 3.9 mmol/L | 6 hours, 12 hours, overnight (midnight to 6am) and 24 hours post-exercise |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |